These findings of increased low-grade inflammation and reduced insulin sensitivity without overt hyperglycemia are consistent with the progression of obesity-related metabolic syndrome in non-pregnant mouse models [15], [16], [26], and the protection afforded to these models by the fat-1 transgene [39]–[41]. The gene discussed is FAT1; the disease is metabolic syndrome.